Alvaro G. Menendez

ORCID: 0000-0003-4921-0474
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 and healthcare impacts
  • Economic and Financial Impacts of Cancer
  • COVID-19 Clinical Research Studies
  • Cancer Treatment and Pharmacology
  • Global Cancer Incidence and Screening
  • Healthcare cost, quality, practices
  • Testicular diseases and treatments
  • Complementary and Alternative Medicine Studies
  • LGBTQ Health, Identity, and Policy
  • Dermatological diseases and infestations
  • Ethics in Clinical Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Colorectal Cancer Treatments and Studies
  • Cancer, Hypoxia, and Metabolism
  • Acupuncture Treatment Research Studies
  • Infection Control and Ventilation
  • Advances in Oncology and Radiotherapy
  • Emergency and Acute Care Studies
  • Erythrocyte Function and Pathophysiology
  • Cancer Risks and Factors
  • Digital Mental Health Interventions
  • Pericarditis and Cardiac Tamponade
  • BRCA gene mutations in cancer
  • Cancer therapeutics and mechanisms

Hartford Hospital
2021-2025

Hartford Financial Services (United States)
2021-2025

Cancer Institute (WIA)
2025

University of Hartford
2024

University of Connecticut
2024

UConn Health
2022

Fundación Renal
2020

Indiana University School of Medicine
2017-2018

Indiana University – Purdue University Indianapolis
2017-2018

Roger Williams Medical Center
2015-2016

Cutaneous reactions after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are poorly characterized.To describe and classify cutaneous SARS-CoV-2 vaccination.A nationwide Spanish cross-sectional study was conducted. We included patients with within 21 days of any dose the approved at time study. After a face-to-face visit dermatologist, information on collected via an online professional survey clinical photographs were sent by email. Investigators searched for consensus...

10.1111/bjd.20639 article EN British Journal of Dermatology 2021-07-13

The HOLA COVID-19 study sought to evaluate the impact of on oncology practices across Latin America (LATAM), challenges faced by physicians, and how physicians adapted while delivering care patients with cancer.This international cross-sectional in LATAM included a 43-item anonymous online survey changes adaptations clinical practice. Multivariable logistic regression analyses were used association caring for practice.A total 704 from 19 countries completed survey. Among respondents, most...

10.1200/go.21.00251 article EN cc-by-nc-nd JCO Global Oncology 2022-03-04
Andrew Schmidt Matthew D. Tucker Ziad Bakouny Chris Labaki Chih–Yuan Hsu and 95 more Yu Shyr Andrew J. Armstrong Tomasz M. Beer Ragneel R. Bijjula Mehmet Asım Bilen Cindy F. Connell Scott J. Dawsey Bryan A. Faller Xīn Gào Benjamin A. Gartrell David Gill Shuchi Gulati Susan Halabi Clara Hwang Monika Joshi Ali Raza Khaki Harry Menon Michael J. Morris Matthew Puc Karen Russell Dimpy P. Shah Neil J. Shah Nima Sharifi Justin Shaya Michael T. Schweizer John A. Steinharter Elizabeth Wulff‐Burchfield Wenxin Xu Jay Zhu Sanjay Mishra Petros Grivas Brian I. Rini Jeremy L. Warner Tian Zhang Toni K. Choueiri Shilpa Gupta Rana R. McKay Aakash Desai Aaron Cohen Adam J. Olszewski Aditya Bardia Ahmad Daher Alaina J. Brown Albert C. Yeh Albert Hsiao Alex Cheng Alice Y. Zhou Alicia Beeghly‐Fadiel Alicia K. Morgans Alokkumar Jha Alvaro G. Menendez Aldo Di Fazio Amanda Nizam Amelie G. Ramírez Amit Kulkarni Amit Verma Amro Elshoury Andrea Verghese Rivera Andrew Walden Andrew J. Piper‐Vallillo Andrew L. Cook Ang Li Angela Shaw Cantrell Angelo Cabal Anju Nohria Anne H. Angevine Anthony P. Gulati Antonio Giordano Anup Kasi Archana Ajmera Arielle Elkrief Ariffa Kariapper Arturo Loaiza‐Bonilla Asha Jayaraj Astha Thakkar Atlantis Dawn Russ Babar Bashir Balázs Halmos Barbara Logan Barbara R. Wood Becky Slawik Becky Dixon Benjamin French Bertrand Routy Blanche H. Mavromatis Brandon Hayes‐Lattin Briana Barrow McCollough Bridget Fleissner Brittany Stith Camille P. Wicher Candice Schwartz Carey C. Thomson Carmen C. Solórzano Carolina Granada CarrieAnn Brown

<h3>Importance</h3> Androgen deprivation therapy (ADT) has been theorized to decrease the severity of SARS-CoV-2 infection in patients with prostate cancer owing a potential tissue-based expression coreceptor transmembrane protease, serine 2 (TMPRSS2). <h3>Objective</h3> To examine whether ADT is associated decreased rate 30-day mortality from among cancer. <h3>Design, Setting, and Participants</h3> This cohort study analyzed patient data recorded COVID-19 Cancer Consortium registry between...

10.1001/jamanetworkopen.2021.34330 article EN cc-by-nc-nd JAMA Network Open 2021-11-12

High levels of growth factors and their receptors have been demonstrated in human tumors. Gliomas meningiomas are characterized by overexpression epidermal factor receptor (EGF-R). Ior egf/r3, is a neutralizing murine monoclonal antibody (MAb) against EGF-R, was generated at the Cuban Institute Oncology. The recognizes EGF-R with high affinity, inhibiting tyrosine kinase activation. A clinical trial conducted brain tumor patients to evaluate toxicity, immunogenicity, benefit escalating doses...

10.1089/02724570152057634 article EN Hybridoma 2001-04-01

The coordination of Fracture Liaison Services (FLS) with Primary Care (PC) is necessary for the continuity care patients fragility fractures. This study proposes a Best Practice Framework (BPF) and performance indicators implementation follow-up FLS-PC in clinical practice Spain.To develop BPF FLS PC Spain to improve fractures.A Steering Committee selected experts from seven Spanish related doctors nurses participate best workshop. Selection criteria were an active identified champion prior...

10.1007/s11657-020-0693-z article EN cc-by Archives of Osteoporosis 2020-04-25

LBA10012 Background: HG affects a substantial percentage of TCS and can contribute to significant morbidity, but few studies have examined the relationship between adverse health outcomes (AHO), taking into account genetic variation. Methods: Eligible were &lt; 55 y at diagnosis treated with only first line chemotherapy after 1990. underwent physical exams genotyping, completed questionnaires regarding 16 AHO behaviors. was defined as serum testosterone ≤ 3.0 ng/mL or use replacement...

10.1200/jco.2017.35.18_suppl.lba10012 article EN Journal of Clinical Oncology 2017-06-13

e18562 Background: Hematopoietic stem cell transplant (HSCT) patients are at increased risk of fever and infection. This study aims to investigate outcomes in this population during their hospitalization. Methods: A total 108 HSCT recipients from 2002-2014 were included retrospective single-center study. Patients if they had a febrile episode defined by IDSA as temperature > 100.4°F while being neutropenic with ANC < 1500 cells/mm3. Gender was equally distributed 53 females 55 males. then...

10.1200/jco.2016.34.15_suppl.e18562 article EN Journal of Clinical Oncology 2016-05-20

Background and objective: The results of studies support the hypothesis that scabies is on rise in Spain. There are also concerns about possible development resistance to treatment an increase atypical presentations. aims this study were describe demographic clinical profile patients with seen by dermatologists Spain, identify emergence forms scabies, explore frequency failures associated risk factors. Methods: We conducted observational, cross-sectional, multicenter data collected...

10.1016/j.ad.2023.08.006 article ES cc-by-nc-nd Actas Dermo-Sifiliográficas 2023-09-09

193 Background: CIPN has a known negative impact on quality of life (QoL) and can be dose-limiting side effect cytotoxic drugs with no generally agreed upon therapeutic intervention. In this study MT was assessed as primary secondary preventive modality symptoms under the hypothesis that it used an effective prophylactic option. Methods: A single arm 10-week prospective (n = 62) pre/post intervention assessment using validated survey instrument adapted from “Peripheral neuropathy associated...

10.1200/jco.2016.34.26_suppl.193 article EN Journal of Clinical Oncology 2016-10-09

e14068 Background: Based on in vitro studies, C6-ceramide has proven synergistic activity with chemotherapeutic drugs several different types of cancer. The aim forthis study was to compare growth inhibition percentage cytostatics 5-fluoruracil (5-FU),oxaliplatin (Ox) and cetuximab (Cet) or without KRAS wild type (KRAS WT)and mutant Mut) colorectal cancer (CRC) cell lines (SW48 SW480,respectively). Through this experiment, the potential benefits combination therapy chemotherapy could be...

10.1200/jco.2016.34.15_suppl.e14068 article EN Journal of Clinical Oncology 2016-05-20

9625 Background: CAM encompasses a diverse group of interventions not generally considered to be part COT. The objective this study is describe the characteristics, factors and patient reported experiences associated with use by patients (pts) receiving Methods: An IRB approved, 14 item questionnaire was offered all pts COT at single institution cancer center over defined 2 mo interval. Demographics, prevalence type used; as well specific questions define oncologist endorsement in...

10.1200/jco.2015.33.15_suppl.9625 article EN Journal of Clinical Oncology 2015-05-20

10.53876/001c.116807 article EN cc-by-sa International Journal of Cancer Care and Delivery 2024-04-30

e24116 Background: Current financial toxicity (FT) screening tools rely on patient-reported risk factors (RF) 1 . Underrepresented populations may not be forthcoming about FT fears due to cultural concerns of treatment withholding or migratory repercussions, if applicable 1–4. Identifying objective RF, such as social determinants health (SDH) and disease-specific (DSF), could reduce in cancer patients healthcare systems. Methods: This was a multi-center retrospective study evaluating SDH DSF...

10.1200/jco.2024.42.16_suppl.e24116 article EN Journal of Clinical Oncology 2024-06-01

68 Background: Clinical trial (CT) diversity remains low despite numerous countermeasures. We investigated barriers to CT participation in our racially/ethnically diverse cancer population while considering loco-regional differences. Methods: An IRB-approved 32-item survey was administered eligible patients English or Spanish depending on patient preference. Comparisons were made between groups with ANOVA for age and chi square tests categorical variables using an alpha of 0.05. Results: 276...

10.1200/op.2024.20.10_suppl.68 article EN JCO Oncology Practice 2024-09-30

619 Background: Cetuximab (Cet) is beneficial for patients with metastatic KRAS Wild type (WT) colorectal cancer (mCRC) only. C6-Ceramide (C6-Cer) can act synergistically chemotherapy to induce cell death. The aim of this study was compare growth inhibition percentage (GIP) cytostatics 5-fluoruracil (5-FU), oxaliplatin (Ox) and Cet or without C6-Cer in WT mutant (KRAS Mut) CRC lines (SW48 SW480, respectively). Methods: Both were incubated IC50 concentrations test drugs. Drug included 0.8µM...

10.1200/jco.2016.34.4_suppl.619 article EN Journal of Clinical Oncology 2016-02-01

e16535 Background: About half of the pts operated for residual RP mass after chemo NSGCT do not benefit from surgery because contains only necrosis. We sought to assess accuracy “intuition” or experienced guess by urologists at a large tertiary referral center identifying malignant tumors (teratoma and/or viable cancer cells) primary disseminated NSGCT. Methods: included with persistent who were referred urology clinic assessment post lymph node dissection (PC RPLND). All had normal tumor...

10.1200/jco.2018.36.15_suppl.e16535 article EN Journal of Clinical Oncology 2018-05-20

Virtual medicine (VM) use increased during the COVID-19 pandemic as it represented a safe alternative to traditional face-to-face health care delivery. This prospective cross-sectional study aimed characterize preferences and perceived barriers VM on basis of language specific sociodemographic variables while also identifying particular subpopulations at risk dissatisfaction regarding VM.An institutional review board-approved, 23-item questionnaire was offered in English Spanish. Examined...

10.1200/op.22.00114 article EN JCO Oncology Practice 2022-10-18

133 Background: Institutional data confirmed that despite Hispanics having a higher morbidity related to COVID19, mortality and outcomes were more favorable compared other ethnic counterparts. We decided study the role of Barrio Advantage (BA), living in ethnically similar communities leading health advantage, by taking into account acculturation our patients hopes identifying potential avenues educate population minimize healthcare delivery gaps. Methods: A 15-item IRB-approved...

10.1200/jco.2020.39.28_suppl.133 article EN Journal of Clinical Oncology 2021-09-21
Coming Soon ...